Natalizumab: Solution concentrate for I.V. infusion 300 mg in 15 mL; Tysabri® Page last updated: 28 October 2022 Public Summary Document (PSD) July 2022 PBAC Meeting - (PDF 350KB) Public Summary Document (PSD) July 2022 PBAC Meeting - (Word 59KB)